John B. Sanfilippo [JBSS] vs Herbalife [HLF] Detailed Stock Comparison
John B. Sanfilippo
NASDAQ
Loading...
Herbalife
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: John B. Sanfilippo wins in 4 metrics, Herbalife wins in 15 metrics, with 0 ties. Herbalife appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | John B. Sanfilippo | Herbalife | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 13.33 | 2.80 | Herbalife |
| Price-to-Book Ratio | 2.11 | -1.41 | Herbalife |
| Debt-to-Equity Ratio | 36.62 | -3.58 | Herbalife |
| PEG Ratio | 13.22 | 4.47 | Herbalife |
| EV/EBITDA | 8.38 | 4.75 | Herbalife |
| Profit Margin (TTM) | 5.00% | 6.59% | Herbalife |
| Operating Margin (TTM) | 10.42% | 10.59% | Herbalife |
| EBITDA Margin (TTM) | 10.42% | 10.59% | Herbalife |
| Return on Equity | 16.58% | -31.74% | John B. Sanfilippo |
| Return on Assets (TTM) | 8.88% | 11.72% | Herbalife |
| Free Cash Flow (TTM) | $73.36M | $163.40M | Herbalife |
| Dividend Yield | 5.32% | N/A | N/A |
| 1-Year Return | -37.95% | 7.22% | Herbalife |
| Price-to-Sales Ratio (TTM) | 0.66 | 0.19 | Herbalife |
| Enterprise Value | $865.39M | $2.95B | Herbalife |
| EV/Revenue Ratio | 0.78 | 0.60 | Herbalife |
| Gross Profit Margin (TTM) | 21.42% | 78.01% | Herbalife |
| Revenue per Share (TTM) | $95 | $48 | John B. Sanfilippo |
| Earnings per Share (Diluted) | $4.72 | $3.18 | John B. Sanfilippo |
| Beta (Stock Volatility) | 0.35 | 0.86 | John B. Sanfilippo |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
John B. Sanfilippo vs Herbalife Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| John B. Sanfilippo | 1.98% | 0.03% | -5.13% | 1.05% | -11.14% | -27.26% |
| Herbalife | 2.81% | -3.17% | -5.66% | 29.75% | 79.26% | 37.13% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| John B. Sanfilippo | -37.95% | -15.18% | -25.34% | 27.12% | 401.94% | 178.73% |
| Herbalife | 7.22% | -70.28% | -82.17% | -68.64% | -35.71% | 19.76% |
Performance & Financial Health Analysis: John B. Sanfilippo vs Herbalife
| Metric | JBSS | HLF |
|---|---|---|
| Market Information | ||
| Market Cap | $732.33M | $917.64M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 67,520 | 2,128,650 |
| 90 Day Avg. Volume | 83,350 | 2,051,860 |
| Last Close | $63.47 | $9.16 |
| 52 Week Range | $58.47 - $102.18 | $5.04 - $10.83 |
| % from 52W High | -37.88% | -15.42% |
| All-Time High | $127.26 (Jun 19, 2023) | $61.77 (Feb 04, 2019) |
| % from All-Time High | -50.13% | -85.17% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.04% | -0.02% |
| Quarterly Earnings Growth | 0.50% | 9.49% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.07% |
| Operating Margin (TTM) | 0.10% | 0.11% |
| Return on Equity (TTM) | 0.17% | -0.32% |
| Debt to Equity (MRQ) | 36.62 | -3.58 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $29.78 | $-6.41 |
| Cash per Share (MRQ) | $0.11 | $3.11 |
| Operating Cash Flow (TTM) | $29.25M | $265.30M |
| Levered Free Cash Flow (TTM) | $-24,891,250 | $274.58M |
| Dividends | ||
| Last 12-Month Dividend Yield | 5.32% | N/A |
| Last 12-Month Dividend | $3.60 | $0.00 |
Valuation & Enterprise Metrics Analysis: John B. Sanfilippo vs Herbalife
| Metric | JBSS | HLF |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 13.33 | 2.80 |
| Forward P/E | 13.22 | 4.47 |
| PEG Ratio | 13.22 | 4.47 |
| Price to Sales (TTM) | 0.66 | 0.19 |
| Price to Book (MRQ) | 2.11 | -1.41 |
| Market Capitalization | ||
| Market Capitalization | $732.33M | $917.64M |
| Enterprise Value | $865.39M | $2.95B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.78 | 0.60 |
| Enterprise to EBITDA | 8.38 | 4.75 |
| Risk & Other Metrics | ||
| Beta | 0.35 | 0.86 |
| Book Value per Share (MRQ) | $29.78 | $-6.41 |
Financial Statements Comparison: John B. Sanfilippo vs Herbalife
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | JBSS | HLF |
|---|---|---|
| Revenue/Sales | $260.91M | $1.26B |
| Cost of Goods Sold | $205.01M | $276.90M |
| Gross Profit | $55.89M | $982.20M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $27.56M | $132.60M |
| EBITDA | $35.10M | $164.90M |
| Pre-Tax Income | $26.14M | $79.00M |
| Income Tax | $5.99M | $29.80M |
| Net Income (Profit) | $20.15M | $49.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | JBSS | HLF |
|---|---|---|
| Cash & Equivalents | $1.30M | $329.40M |
| Total Current Assets | $349.20M | $1.09B |
| Total Current Liabilities | $173.99M | $1.13B |
| Long-Term Debt | $31.07M | $2.14B |
| Total Shareholders Equity | $346.61M | $-736.00M |
| Retained Earnings | $207.97M | $-757.60M |
| Property, Plant & Equipment | $28.87M | $633.90M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | JBSS | HLF |
|---|---|---|
| Operating Cash Flow | $-25.99M | $-10.30M |
| Capital Expenditures | $-11.68M | $-18.30M |
| Free Cash Flow | $-37.58M | $-18.10M |
| Debt Repayment | $-248,000 | $-70.30M |
| Common Stock Repurchase | N/A | $-2.20M |
Short Interest & Institutional Ownership Analysis
| Metric | JBSS | HLF |
|---|---|---|
| Shares Short | 201,211 | 13.19M |
| Short Ratio | 2.19 | 7.28 |
| Short % of Float | 0.03% | 0.15% |
| Average Daily Volume (10 Day) | 67,520 | 2,128,650 |
| Average Daily Volume (90 Day) | 83,350 | 2,051,860 |
| Shares Outstanding | 11.60M | 101.20M |
| Float Shares | 9.01M | 86.00M |
| % Held by Insiders | 0.02% | 0.02% |
| % Held by Institutions | 0.93% | 1.04% |
Dividend Analysis & Yield Comparison: John B. Sanfilippo vs Herbalife
| Metric | JBSS | HLF |
|---|---|---|
| Last 12-Month Dividend | $3.60 | $0.00 |
| Last 12-Month Dividend Yield | 5.32% | N/A |
| 3-Year Avg Annual Dividend | $3.78 | $0.00 |
| 3-Year Avg Dividend Yield | 1.87% | N/A |
| 3-Year Total Dividends | $11.35 | $0.00 |
| Ex-Dividend Date | Aug 19, 2025 | N/A |